Eric Johnston, Cantor Fitzgerald chief equity and macro strategist, joins 'Closing Bell' to discuss the bullish case for ...

Small-caps often see upward moves around the presidential election. A Trump win would boost the sector even further, Cantor ...

Fintel reports that on October 18, 2024, Cantor Fitzgerald downgraded their outlook for Lilium N.V. (NasdaqGS:LILM) from ...

The global boss of Cantor Fitzgerald, which holds a lucrative contract to sell Irish government bonds, has claimed the budget ...

Cantor Fitzgerald upgraded shares of Tourmaline Bio (NASDAQ:TRML – Free Report) to a strong-buy rating in a report published ...

Cantor Fitzgerald raised the firm’s price target on UnitedHealth to $644 from $591 and keeps an Overweight rating on the ...

Cantor Fitzgerald said it’s bullish on the Russell 2000 (RTY) as it sees higher chances of former President Donald Trump ...

Cantor Fitzgerald Infrastructure Fund (the "Fund") today announced a third-quarter distribution of $0.1170 per Class A share (NASDAQ: CAFIX), $0.1156 per Class C share (NASDAQ: CFCIX), $0.1172 per ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 60.77% ...

Stifel has recently initiated Janux Therapeutics Inc (JANX) stock to Buy rating, as announced on September 6, 2024, according to Finviz. Earlier, on May 30, 2024, Scotiabank had initiated the stock to ...

Cantor Fitzgerald analyst Ross Osborn maintained a Hold rating on Aspira Women’s Health (AWH – Research Report) yesterday and set a ...

Cytokinetics (NASDAQ:CYTK – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at Needham ...